Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

GeneDx Holdings (WGS) Other Non Operating Income: 2019-2024

Historic Other Non Operating Income for GeneDx Holdings (WGS) over the last 6 years, with Dec 2024 value amounting to -$13.0 million.

  • GeneDx Holdings' Other Non Operating Income fell 115.21% to -$174,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$440,000, marking a year-over-year increase of 96.44%. This contributed to the annual value of -$13.0 million for FY2024, which is 903.83% down from last year.
  • Latest data reveals that GeneDx Holdings reported Other Non Operating Income of -$13.0 million as of FY2024, which was down 903.83% from $1.6 million recorded in FY2023.
  • GeneDx Holdings' 5-year Other Non Operating Income high stood at $5.1 million for FY2021, and its period low was -$13.0 million during FY2024.
  • In the last 3 years, GeneDx Holdings' Other Non Operating Income had a median value of $57,000 in 2022 and averaged -$3.8 million.
  • In the last 5 years, GeneDx Holdings' Other Non Operating Income spiked by 2,740.35% in 2023 and then plummeted by 903.83% in 2024.
  • GeneDx Holdings' Other Non Operating Income (Yearly) stood at $2.6 million in 2020, then soared by 95.04% to $5.1 million in 2021, then plummeted by 98.89% to $57,000 in 2022, then spiked by 2,740.35% to $1.6 million in 2023, then slumped by 903.83% to -$13.0 million in 2024.